Analyst Ratings for Globus Medical (GMED)
GMED Rating Summary
GMED Price Target Summary
- Highest: $123.00 (Barclays)
- Lowest: $90.00 (Piper Sandler)
- Average: $104.69
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$104.69 (+20.2%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 77%
Avg. $ Target:
$104.69 (+20.2%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 77%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/30/2026 | Needham » Updated 2/25/2026 |
Mike Matson | Upgrade | Buy (Hold) |
114.00 (112.00) |
90.22 (87.10) |
-3.46% | Details |
| 1/27/2026 | TD Cowen » Updated 2/25/2026 |
Matthew Blackman | New Coverage | Buy (N/A) |
112.00 (110.00) |
92.52 (87.10) |
-5.86% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
